Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality.
Thineskrishna Anbarasan, Sheikh Nissar, Julie Turbitt, Kathryn Walls, Sarah McLuckie, Caroline Clark, Jean-Christophe Bourdon, Joel Tracey, Susan Bray, Atlaf Shamsuddin, Jason Alcorn, Sunjay Jain, Robert Hislop, Chandra Shekhar Biyani, Ghulam Nabi
{"title":"Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality.","authors":"Thineskrishna Anbarasan, Sheikh Nissar, Julie Turbitt, Kathryn Walls, Sarah McLuckie, Caroline Clark, Jean-Christophe Bourdon, Joel Tracey, Susan Bray, Atlaf Shamsuddin, Jason Alcorn, Sunjay Jain, Robert Hislop, Chandra Shekhar Biyani, Ghulam Nabi","doi":"10.1177/00369330221134233","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Urinary bladder recurrences (UBRs) after radical nephroureterectomy (RNUx) are a known challenge in patients with upper-tract urothelial cancers (UTUCs). We aim to assess factors associated with UBR and clonal-relatedness with resected UTUC.</p><p><strong>Methods: </strong>Patients who underwent RNUx for UTUC between 1998 and 2015 in five institutions were identified. Clonal relatedness between primary UTUC and subsequent UBR in a sub-cohort was assessed using next-generation sequencing. A Kaplan-Meier curve was used to assess differences in UBR between two groups (with or without ureteroscopic biopsy).</p><p><strong>Results: </strong>Of 267 patients with complete records, 73 (27.3%) had UBR during follow-up. The five-year UBR-free survival in all patients was 64.7%. The five-year UBR-free-survival was inferior in patients who underwent URS biopsy compared with patients who did not undergo ureteroscopic biopsy (49.9% vs 76.4%, <i>p</i> < 0.001). History of bladder tumour (HR, 95% CI; 2.94, 1.73-5.00, <i>p</i> < 0.001), ureteroscopic biopsy (HR, 95% CI; 2.21, 1.38-3.53, <i>p</i> = 0.001) and preoperative urine cytology ≥C3 (HR, 95% CI; 2.06, 1.24-3.40, <i>p</i> = 0.005) were independently associated with UBR. Patients with ureteroscopic biopsy (n = 3/5) showed identical mutational changes for common genes (<i>TP53</i> and <i>FGFR3</i>) between primary UTUC and subsequent UBR.</p><p><strong>Conclusions: </strong>Ureteroscopic biopsy of UTUC is a significant risk factor for UBR. Qualitative clonality assessment showed identical mutational signatures between primary UTUC and UBR.</p>","PeriodicalId":21683,"journal":{"name":"Scottish Medical Journal","volume":"68 1","pages":"4-13"},"PeriodicalIF":1.4000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scottish Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00369330221134233","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 3
Abstract
Background and aims: Urinary bladder recurrences (UBRs) after radical nephroureterectomy (RNUx) are a known challenge in patients with upper-tract urothelial cancers (UTUCs). We aim to assess factors associated with UBR and clonal-relatedness with resected UTUC.
Methods: Patients who underwent RNUx for UTUC between 1998 and 2015 in five institutions were identified. Clonal relatedness between primary UTUC and subsequent UBR in a sub-cohort was assessed using next-generation sequencing. A Kaplan-Meier curve was used to assess differences in UBR between two groups (with or without ureteroscopic biopsy).
Results: Of 267 patients with complete records, 73 (27.3%) had UBR during follow-up. The five-year UBR-free survival in all patients was 64.7%. The five-year UBR-free-survival was inferior in patients who underwent URS biopsy compared with patients who did not undergo ureteroscopic biopsy (49.9% vs 76.4%, p < 0.001). History of bladder tumour (HR, 95% CI; 2.94, 1.73-5.00, p < 0.001), ureteroscopic biopsy (HR, 95% CI; 2.21, 1.38-3.53, p = 0.001) and preoperative urine cytology ≥C3 (HR, 95% CI; 2.06, 1.24-3.40, p = 0.005) were independently associated with UBR. Patients with ureteroscopic biopsy (n = 3/5) showed identical mutational changes for common genes (TP53 and FGFR3) between primary UTUC and subsequent UBR.
Conclusions: Ureteroscopic biopsy of UTUC is a significant risk factor for UBR. Qualitative clonality assessment showed identical mutational signatures between primary UTUC and UBR.
背景和目的:根治性肾输尿管切除术(RNUx)后膀胱复发(UBRs)是上尿路上皮癌(UTUCs)患者的一个已知挑战。我们的目的是评估与UBR相关的因素以及与切除的UTUC的克隆相关性。方法:选取1998年至2015年间在5家医院因UTUC接受RNUx治疗的患者。使用下一代测序评估亚队列中原发性UTUC和随后的UBR之间的克隆相关性。Kaplan-Meier曲线用于评估两组间UBR的差异(有或没有输尿管镜活检)。结果:267例记录完整的患者中,73例(27.3%)在随访期间发生UBR。所有患者的5年无ubr生存率为64.7%。接受尿路穿刺活检的患者5年无ubr生存率低于未接受输尿管镜活检的患者(49.9% vs 76.4%, p p p = 0.001),且术前尿细胞学≥C3 (HR, 95% CI;2.06, 1.24-3.40, p = 0.005)与UBR独立相关。输尿管镜活检患者(n = 3/5)在原发性UTUC和随后的UBR之间显示相同的常见基因(TP53和FGFR3)突变变化。结论:UTUC输尿管镜活检是UBR的重要危险因素。定性克隆性评价显示,原发UTUC和UBR的突变特征相同。
期刊介绍:
A unique international information source for the latest news and issues concerning the Scottish medical community. Contributions are drawn from Scotland and its medical institutions, through an array of international authors. In addition to original papers, Scottish Medical Journal publishes commissioned educational review articles, case reports, historical articles, and sponsoring society abstracts.This journal is a member of the Committee on Publications Ethics (COPE).